Sun Pharma Q3 results: Driven by strong sales, profits beat estimates

Posted on by


India’s Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in key markets such as the United States.


The company reported a consolidated profit after tax of 25.24 billion rupees ($304 million) for the quarter ended Dec. 31, beating analysts’ estimate of 24.17 billion rupees as per LSEG data.


($1 = 83.0000 Indian rupees)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Jan 31 2024 | 2:52 PM IST